ENvue Medical, Inc. cash flow to debt ratio of -782.96% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

ENvue Medical, Inc.'s free cash flow has decreased 274.43% from $-2.52M last year to $-9.43M, signaling decreasing performance

ENvue Medical, Inc.'s debt to equity ratio is 0.04, which means that the company's assets are healthy financed, signaling financial stability.

ENvue Medical, Inc.'s debt has decreased relative to shareholder equity from 0.19 last year to 0.04 today, signaling strengthened financials

ENvue Medical, Inc. has a net cash position, so leverage is healthy.

ENvue Medical, Inc.'s interest coverage ratio is -50.16, which means that the company struggles to meet interest obligations, signaling financial risk.

ENvue Medical, Inc.'s profit margin has decreased (413.78%) in the last year from -144.84% to -744.15%, signaling decreasing performance

ENvue Medical, Inc.'s short-term assets of $7.27M exceed its short-term liabilities of $6.66M

ENvue Medical, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

ENvue Medical, Inc.'s return on equity of -43.73%, is lower than 15.00%, indicating bad performance

ENvue Medical, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

ENvue Medical, Inc. has insufficient public price history to evaluate earnings stability.

ENvue Medical, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

ENvue Medical, Inc. has negative free cash flow, indicating cash burn

ENvue Medical, Inc.'s yearly earnings has decreased 390.82% since last year from $-3.71M to $-18.18M, signaling decreasing performance

ENvue Medical, Inc.'s yearly revenue has decreased 0.20% since last year from $2.56M to $2.55M, signaling decreasing performance

ROIC -39.21% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

ENvue Medical, Inc.'s 3-year revenue CAGR of 50.29% is positive, indicating growing revenue over the past 3 years

ENvue Medical, Inc. has insufficient public price history to evaluate revenue consistency.

ENvue Medical, Inc. has insufficient public price history to evaluate ROE consistency.

ENvue Medical, Inc. has insufficient data to evaluate this check.

ENvue Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

ENvue Medical, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

ENvue Medical, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

ENvue Medical, Inc. is overvalued relative to its fair value price of -192.99 based on Earnings Fair Value model

ENvue Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

ENvue Medical, Inc. has a price-to-book ratio of 0.00x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

ENvue Medical, Inc. has a price-to-sales ratio of 0.00x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue